Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu

The Best CRISPR Companies to Invest In

These CRISPR stocks could be big winners for patient investors.

By Keith Speights – Updated Nov 1, 2024 at 4:43PM

Key Points

  • CRISPR stocks are high risk but hold potential for aggressive investors.
  • CRISPR Therapeutics and its partner Vertex Pharmaceuticals have the only approved CRISPR therapy.
  • Several other biotech companies have CRISPR therapies in clinical testing.
Key findings are powered by ChatGPT and based solely off the content from this article. Findings are reviewed by our editorial team. The author and editors take ultimate responsibility for the content.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.